Results 261 to 270 of about 9,370 (298)
Some of the next articles are maybe not open access.
Regulating Compounding Pharmacies.
NCSL legisbrief, 2015(1) The Pew Charitable Trusts identified 27 compounding incidents that resulted in 89 deaths since 2001. (2) Unlike drug manufacturers, compounding pharmacies are generally not required to report adverse events associated with their products to the FDA. (3) Federal law on drug compounding was updated in 2013 to create a new group of compounders called "
openaire +2 more sources
Regulating Compounding Pharmacies after NECC
New England Journal of Medicine, 2012FDA rules are often forged in crisis. Compounding pharmacies are at the center of a controversy after an outbreak of fungal meningitis that was traced to methylprednisolone acetate from the New England Compounding Center. Congress is already discussing new regulations.
openaire +2 more sources
Indocyanine green availability from compounding pharmacies
American Journal of Health-System Pharmacy, 2008Indocyanine green for injection (IC-Green, Akorn Inc., Buffalo Grove, IL) is a sterile, lyophilized green powder dye containing 25 mg of drug with no more than 5% sodium iodide. The drug is used for several diagnostic purposes, including determining cardiac output and hepatic function, and ...
Richard, Cramer +2 more
openaire +2 more sources
NABP to inspect compounding pharmacies
American Journal of Health-System Pharmacy, 2013The National Association of Boards of Pharmacy (NABP) in December launched a nationwide program to identify and inspect compounding pharmacies. NABP Executive Director Carmen Catizone, speaking December 5 at ASHP’s Midyear Clinical Meeting in Las Vegas, said critical information about ...
openaire +1 more source
Compounding from a Pharmacy Student's Perspective: Staying Competitive as a Compounding Pharmacy.
International journal of pharmaceutical compounding, 2019The International Academy of Compounding Pharmacists Foundation held a student essay contest in the Spring of 2018. Two great submissions were chosen to receive an award. This article features one of the chosen essays, which discusses some of the challenges that compounding pharmacies face in the competitive profession of pharmacy.
openaire +1 more source
Carbowax Compounds in Pharmacy
Journal of the American Pharmaceutical Association (Practical Pharmacy ed.), 1949C P, McCLELLAND, R L, BATEMAN
openaire +2 more sources
[Pharmacy compounding of an omeprazole suspension].
Journal de pharmacie de Belgique, 2009The problems of preparation of different pharmaceutically compounded formulations of prescribed omeprazole suspensions are discussed. Problems that can be cited are: inadequate preparation, chemical and physical stability problems, taste problems and low bioavailability. The formulation of the omeprazole suspension is optimized, taking into account the
F, Van Der Straeten +4 more
openaire +1 more source
Orodispersible Films for Compounding Pharmacies.
International journal of pharmaceutical compounding, 2018Orodispersible film can be defined as a solid pharmaceutical form intended for the delivery and rapid local or systemic release of active ingredients, consisting of a water-soluble polymer film that hydrates rapidly, adhering and dissolving immediately when placed on the tongue or in the oral cavity (oral, palatal, gingival, lingual, or sublingual ...
Anderson O, Ferreira +4 more
openaire +1 more source

